Skip to main content
HealthReportedMediumDeveloping
4.8

Irish HSE review: Wegovy reimbursement possible but billions in cost

An Irish health technology review suggests the HSE could reimburse Wegovy for certain patient groups, but estimates the cost in the billions. The decision is pending and hinges on budget allocation and clinical criteria. This signals a potential major expansion of public access to weight-loss drugs in Ireland.

Irish Independentabout 11 hours agoIEengCredibility 19%View source

Score Breakdown

Mosaic Score4.8
Model confidence0.5
Significance0.5
Source credibility0.2
Source

Related signals

8 found